PRESS RELEASE published on 05/11/2023 at 22:25, 1 year 4 months ago Zomedica Announces Record First Quarter 2023 Financial Results: Revenue up 45% to $5.5 Million; Strong 70% Gross Margin & $147.5 Million in Liquidity
PRESS RELEASE published on 05/08/2023 at 12:30, 1 year 4 months ago Zomedica Exercises Option to Acquire Structured Monitoring Products
PRESS RELEASE published on 05/02/2023 at 12:30, 1 year 4 months ago Zomedica to Host First Quarter Financial Results Call on May 11
PRESS RELEASE published on 04/18/2023 at 12:30, 1 year 5 months ago Zomedica to Present at H.C. Wainwright 24th Annual Global Investment Conference
PRESS RELEASE published on 03/17/2023 at 11:30, 1 year 6 months ago Zomedica Appoints New Chief Financial Officer
PRESS RELEASE published on 03/15/2023 at 21:45, 1 year 6 months ago Zomedica Corporation Reports 2022 Results: $18.9 Million Revenue; 72% Gross Margin & $156 Million in Liquidity - Revenue up 361% from 2021 through combination of acquisitions and organic growth
PRESS RELEASE published on 03/08/2023 at 12:30, 1 year 6 months ago Zomedica to Host Fourth Quarter and Fiscal Year 2022 Financial Results Call on March 15
PRESS RELEASE published on 02/09/2023 at 12:30, 1 year 7 months ago Zomedica Reports Preliminary Results for the Fourth Quarter and Full Year 2022
PRESS RELEASE published on 01/24/2023 at 12:00, 1 year 8 months ago Zomedica to Participate in the Lytham Partners Investor Select Conference
PRESS RELEASE published on 01/18/2023 at 12:00, 1 year 8 months ago Zomedica to Take Control of New Assay Development and Manufacturing of TRUFORMA Product Line through Long-Term Licensing Agreement with Qorvo Biotechnologies
Published on 09/28/2024 at 02:06, 1 day ago Global Education Communities Corp. Reports Second Tranche Closing of Non-Brokered Private Placement
Published on 09/28/2024 at 02:00, 1 day ago bettermoo(d)’s Moodrink(TM) Featured in Banners of Well-Known Canadian Retailers
Published on 09/28/2024 at 00:10, 1 day 2 hours ago LQWD Technologies Announces Non-Brokered Private Placement Update
Published on 09/28/2024 at 14:01, 12 hours 13 minutes ago Turkiye Garanti Bankasi A.S.: Explanation on Subordinated Debt Securities to Qualified Investors
Published on 09/27/2024 at 22:30, 1 day 3 hours ago DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
Published on 09/27/2024 at 21:56, 1 day 4 hours ago EQS-Adhoc: FDA grants approval for Stelara® Biosimilar FYB202/OtulfiTM (ustekinumab-aauz)
Published on 09/27/2024 at 18:50, 1 day 7 hours ago PETROFAC ANNOUNCES IN-PRINCIPLE AGREEMENT ON FINANCIAL RESTRUCTURE
Published on 09/27/2024 at 18:40, 1 day 7 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/27/2024 at 17:45, 1 day 8 hours ago NFL BIOSCIENCES: 2024 FIRST-HALF BUSINESS AND EARNINGS UPDATE
Published on 09/26/2024 at 18:00, 2 days 8 hours ago GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2024
Published on 09/26/2024 at 18:00, 2 days 8 hours ago GUILLEMOT CORPORATION: 2024 CONSOLIDATED INTERIM RESULTS
Published on 09/26/2024 at 17:47, 2 days 8 hours ago imerys-26-September-2024-information-share-capital-and-voting-rights-as-of-31-August-2024